Residential depression treatment for Delray Beach — TMS and ketamine in-house.

RECO Immersive's residential campus is inside Delray Beach — 140 NE 4th Avenue, one block off Atlantic Avenue and five minutes on foot from the ocean. Clients from Pineapple Grove, Lake Ida, Tropic Isle, the Beach District, and Osceola Park enter 24-hour residential care without leaving the city, then step down to PHP, IOP, and outpatient with the same psychiatrist and primary therapist. In-house rTMS and ketamine access means escalation from failed outpatient antidepressant trials happens in one setting rather than across three referrals.

The RECO Immersive residential campus sits at 140 NE 4th Avenue, one block off Atlantic Avenue and a five-minute walk from the Atlantic. For adults living in Pineapple Grove, Lake Ida, Tropic Isle, the Beach District, or Osceola Park, entering residential depression treatment does not require leaving Delray Beach — the compressed clinical block happens inside the same neighborhood the client will return to when they step down. That continuity matters when the depressive episode has already made every logistical decision feel impossible.

When residential depression treatment is the right level of care

Residential is the correct level of care when depressive severity has broken the outpatient container. The typical presentation entering RECO Immersive from Delray Beach and greater Palm Beach County is a PHQ-9 in the 15 to 27 range that has not moved despite two or more adequate outpatient antidepressant trials — an SSRI such as sertraline or escitalopram at therapeutic dose for at least six weeks, often followed by an SNRI (venlafaxine or duloxetine) or bupropion, without meaningful movement on scale.

Other presentations that fit this level of care: recent inpatient psychiatric hospitalization with residual symptoms that will not tolerate a direct return to outpatient; profound anergia and functional collapse — the client cannot reliably shower, attend an IOP schedule, or hold employment; and treatment-resistant depression where the next reasonable step is a course of rTMS or a ketamine induction paired with observed oral medication adherence and structured sleep.

Passive suicidal ideation without plan, intent, or means frequently belongs at this level; active suicidal crisis with means and intent belongs on an inpatient psychiatric unit, and admissions will refer accordingly. The residential depression treatment track is a step-up from outpatient failure, not a substitute for acute stabilization.

The first seventy-two hours in residential

The intake window is deliberately front-loaded. A full psychiatric evaluation happens within twenty-four hours of admission, including a reconstruction of every prior antidepressant trial with attention to dose, duration, and reason for discontinuation — the trial history that outpatient clinicians rarely have time to assemble. Baseline PHQ-9, GAD-7, and Columbia Suicide Severity Rating Scale scores are documented.

Sleep is stabilized on day one, often with a short course of trazodone or low-dose mirtazapine where indicated, because sleep is both a symptom and a driver of the depressive course. Concurrent medical contributors — untreated hypothyroidism, low ferritin, obstructive sleep apnea, deficient vitamin D — are worked up, because they are common in a chronically depressed population and treating them meaningfully shifts the antidepressant response curve.

Concurrent TMS or ketamine during the residential stay

The load-bearing clinical advantage of residential over standalone outpatient interventional psychiatry is the surrounding structure. A client on an outpatient rTMS course delivered at 3000 pulses per session at 120% of motor threshold, five days a week for approximately six weeks, is still responsible for their own sleep schedule, adherence to the concurrent oral antidepressant, and the affective volatility that appears mid-course. In residential the treatment team owns those variables.

Clients who have failed two or more adequate outpatient antidepressant trials frequently begin rTMS or an intranasal esketamine or IV ketamine induction within the first two weeks of admission. The psychiatry team stages the interventional escalation as part of the residential treatment plan rather than as a downstream referral. Ketamine sessions are followed by same-day integration therapy — the dissociative window is a poor time to be sent home alone in a car. Concurrent oral trials are observed rather than assumed, which is meaningful in a population where adherence has often been the confound in the outpatient trial history.

Behavioral Activation, CBT for depression, and the daily structure

Depression’s behavioral withdrawal — the collapse of rewarding activity, mastery experience, and social contact — is directly targeted by the residential daily structure. Behavioral Activation is delivered as a formal protocol modeled on Martell and Dimidjian: activity monitoring, values clarification, graded activity scheduling, and functional analysis of avoidance patterns. It is not the generic “get outside and move” advice that depressed clients have already been offered and failed to enact.

Cognitive Behavioral Therapy for depression targets the automatic thoughts and ruminative loop that maintain the disorder — thought records, behavioral experiments to test predictions of failure or rejection, and rumination-focused CBT where repetitive negative thinking is the primary residual symptom. Interpersonal Therapy is delivered where the depressive episode is anchored in grief, role transition, or interpersonal dispute. Adjunctive modalities include ACT for values-based re-engagement, DBT skills for clients with co-occurring emotion dysregulation, and EMDR where trauma is a driver, delivered with appropriate stabilization work first.

Medication management and the psychiatric decisions residential enables

Residential is where medication decisions that would otherwise take months on an outpatient calendar happen in weeks. Augmentation of a partially responding SSRI with lithium, aripiprazole, or quetiapine is common; a rational cross-taper from a failed agent to a mechanistically different class is another. In-house observation catches side effects — akathisia on aripiprazole, sedation on quetiapine, the early tremor on lithium, activation on bupropion — before they collapse adherence at home.

Every admission is screened for bipolar spectrum illness using the MDQ and a careful history of prior hypomanic episodes, because an antidepressant monotherapy given to a bipolar II client is a well-documented driver of what looks like “treatment-resistant depression.” Co-occurring generalized anxiety is quantified with the GAD-7, adult ADHD with the ASRS, and OCD with the YBOCS where indicated. Substance use is assessed against ASAM Criteria dimensions and, where present, integrated into the plan — untreated alcohol or cannabis use is a common maintaining factor in depression that has been misread as medication-unresponsive.

The step-down when depression starts to lift

The residential block is a compressed clinical intervention, not the entire treatment. As PHQ-9 trajectory improves and functional capacity returns — the client is sleeping on schedule, participating in group, tolerating discomfort without shutdown — the team steps them down to the partial hospitalization program at RECO Health, which runs 30-plus clinical hours weekly with the client sleeping in supported housing or at home in Delray Beach at night. From PHP the taper continues to intensive outpatient (nine to twelve clinical hours weekly) and then to standard outpatient with continued psychiatry.

The primary therapist and psychiatrist follow the client across levels of care rather than handing off, which is what protects gains through the vulnerable first ninety days after discharge — the window when relapse rates are highest and coordination failures are most consequential.

Admissions and insurance from Delray Beach

Admissions runs a same-day verification of benefits against most commercial plans, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and Blue Cross Blue Shield. Utilization review is handled in-house; for residential mental health, commercial plans authorize based on documented severity, prior outpatient trials, and safety concerns rather than length of stay in advance. For Delray Beach residents the logistics are unusually simple — the residential campus is inside the city, so admissions can meet the client and one family member on site for a clinical assessment before the decision to admit, reducing the friction of committing to residential when the depressive episode is already narrowing decision-making capacity.

Serving residents of: Pineapple Grove, Lake Ida, Tropic Isle, Beach District, Osceola Park.